Basic Sciencemoderate evidence
A human organoid drug screen identifies α2-adrenergic receptor signaling as a therapeutic target for cartilage regeneration.
Cell stem cell·December 5, 2024·PMID 39353427
Why it mattersIt identifies a repurposable drug target (α2-AR/SLPI) for cartilage regeneration, addressing the major barrier of hypertrophic degeneration in stem cell-based therapies. This could inform future clinical strategies for osteoarthritis and cartilage defects.

The papers that matter, first.
MedLit ranks the medical literature into a specialty feed with concise summaries, evidence-aware triage, and visual takeaways.
§
MedLit · Evidence, Distilled